All lobbying filings

BRIDGEBIO PHARMA, INC.

Lobbying for BRIDGEBIO PHARMA, INC. · Biotech company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $420,000.00 expenses · posted Apr 20, 2026

Official filing document

Bills named in this filing 2

HR 7148
Consolidated Appropriations Act, 2026
HR 1262
Mikaela Naylon Give Kids a Chance Act

Lobbying activity 1

Pharmacy

H.R.7148 - Consolidated Appropriations Act, 2026 Give Kids a Chance Act of 2025 - H.R. 1262; S 932 Orphan drug policies General issues and provisions related to PBM Reform

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.